Dual-action inhibitors and methods of using same

Details for Australian Patent Application No. 2010242800 (hide)

Owner Aerie Phamaceuticals, Inc.

Inventors Delong, Mitchell A.; Sturdivant, Jill Marie; Royalty, Susan M.; Heintzelman, Geoffrey Richard; Yingling, Jeffrey D.; Kopczynski, Casey

Agent Griffith Hack

Pub. Number AU-A-2010242800

PCT Pub. Number WO2010/127330

Priority 61/174,672 01.05.09 US

Filing date 1 May 2010

Wipo publication date 4 November 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/127330 Priority application(s): WO2010/127330

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010242811-Earpiece system

2010242797-Enterprise client-server system and methods of providing web application support through distributed emulation of websocket communications